NCT Number: NCT00576342
Patient Preference Study
In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Sign informed consent;
- Diagnosis of glaucoma or ocular hypertension;
- On a stable regimen of any intraocular pressure (IOP) lowering medication (mono-therapy);
- IOP for which, in the opinion of the investigator, participation in the study does not present a risk to ocular health;
- Other protocol-defined inclusion criteria may apply.
Exclusion criteria
- Best corrected visual acuity worse than 0.60 logMAR (20/80 Snellen) in either eye;
- Pregnant, nursing, or not using highly effective birth control methods;
- Use of oral or topical corticosteroids within 30 days of the Screening Visit and during the course of the study;
- History of bronchial asthma or severe chronic obstructive pulmonary disease;
- Other protocol-defined exclusion criteria may apply.
Treatment and study plan
Dorzolamide+timolol ophthalmic solution
DrugOther names: COSOPT
Primary outcomes
-
Percentage of patients with a stated preference for either study medication
Time frame: Day 2
Secondary outcomes
-
Mean ocular discomfort score
Time frame: Day 1, 1 minute after drop instillation
Sponsors and collaborators
Lead sponsor
Alcon Research
Industry
Registry information
Official study title
A Single Dose Patient Preference Study Comparison in Patients With Open-Angle Glaucoma or Ocular Hypertension
Important dates
- Study start
- 2007
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Dec 19, 2007
- Registry last updated
- Jul 11, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SD-OCT Multimodal Analysis in GLaucoma
NCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial Details24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
NCT06689696
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Fullerton, California, United States
View Trial DetailsEfficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT06394973
Eye Diseases, Glaucoma
Glendale, Arizona, United States
View Trial DetailsEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma
NCT07154797
Cataract, Eye Diseases
Santa Rosa de Copán, Honduras
View Trial Details